Icariin inhibits inflammation via immunomodulation of the cutaneous hypothalamus-pituitary-adrenal axis <i>in vitro</i>

Abstract

Icariin has a regulatory effect on steroidogenesis in HaCaT cells, which may provide a promising therapeutic target for the treatment of inflammatory skin disorders.